CVRx Inc. (CVRX)
6.26
0.11 (1.79%)
At close: Apr 17, 2025, 3:59 PM
6.30
0.52%
After-hours: Apr 17, 2025, 04:57 PM EDT
1.79% (1D)
| Bid | 5.76 |
| Market Cap | 163.12M |
| Revenue (ttm) | 51.29M |
| Net Income (ttm) | -59.97M |
| EPS (ttm) | -2.65 |
| PE Ratio (ttm) | -2.36 |
| Forward PE | -3.66 |
| Analyst | Buy |
| Ask | 7.32 |
| Volume | 215,769 |
| Avg. Volume (20D) | 330,557 |
| Open | 6.06 |
| Previous Close | 6.15 |
| Day's Range | 6.06 - 6.28 |
| 52-Week Range | 5.87 - 18.55 |
| Beta | 1.29 |
About CVRX
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributo...
Industry Medical - Devices
Sector Healthcare
IPO Date Jun 30, 2021
Employees 206
Stock Exchange NASDAQ
Ticker Symbol CVRX
Website https://www.cvrx.com
Analyst Forecast
According to 7 analyst ratings, the average rating for CVRX stock is "Buy." The 12-month stock price forecast is $16, which is an increase of 155.39% from the latest price.
Stock ForecastsNext Earnings Release
CVRx Inc. is scheduled to release its earnings on May 8, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+5.11%
CVRx sahres are trading lower after the company re...
Unlock content with
Pro Subscription
3 months ago
+7.38%
CVRx shares are trading higher after William Blair upgraded the stock from Market Perform to Outperform.
